ASTH250117P40000
- 4.20
- 0.000.00%
Astrana Health Newsroom
Macquarie Initiates Astrana Health(ASTH.US) With Hold Rating, Announces Target Price $41
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
Astrana Health's Strategic Acquisitions and Value-Based Care Drive Bullish Buy Rating
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $86
Astrana Health Analyst Ratings
Baird Maintains Outperform on Astrana Health, Raises Price Target to $86
Lake Street Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $70
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $66
Lake Street Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $70
Stifel Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $70
TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $66
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $67
TD Cowen Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $66
TD Cowen Initiates Coverage On Astrana Health With Buy Rating, Announces Price Target of $66
BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $70
Astrana Health Analyst Ratings
BTIG Keeps Their Buy Rating on Astrana Health (ASTH)